Bristol Myers (BMY) delivered an impressive performance in the past month after being under pressure for quite some time. The ...

First Devices Customized for a Plasma-Derived Therapy in Takeda’s Broad and Differentiated Portfolio Reflect Company’s Commitment to Providing a Patient-Centric Ecosystem of Support Takeda ...

Blood donor selection is crucial for ensuring safe blood supply. A well-designed donor selection system helps in maintaining donor engagement by minimizing unnecessary exclusion while safeguarding ...

Immune checkpoint inhibitors (ICIs), a powerful form of immunotherapy, have revolutionized cancer treatment by unleashing the ...

A new study presented at the 2025 International Conference on Malignant Lymphoma (ICML) has shown that radiation therapy can ...

An antibody treatment developed at Stanford Medicine successfully prepared patients for stem cell transplants without toxic ...

Precision-targeted therapy via antibody drugs has become central to the field of cancer immunotherapy. Monoclonal antibodies ...

The 2025 EHA Congress Awards honoured outstanding contributions across clinical care, research, education, and advocacy in ...

A research team has successfully tested a blood substitute in animals, and human trials may not be far off. The powdered ...